Economic Appraisal in the Regulation of Pharmaceuticals in Australia: Its Rationale and Potential Impact

This publication has 14 references indexed in Scilit:

• A Macro Approach to Economic Appraisal in the Health Sector
  Australian Economic Review, 1994
• The qaly—a measure of social value rather than individual utility?
  Health Economics, 1994
• Cost-effectiveness league tables: More harm than good?
  Social Science & Medicine, 1993
• Cost‐effectiveness guidelines for reimbursement of pharmaceuticals: Is economic evaluation ready for its enhanced status?
  Health Economics, 1992
• Issues in the Cross-National Assessment of Health Technology
  International Journal of Technology Assessment in Health Care, 1992
• Avoiding Bias in the Conduct and Reporting of Cost-Effectiveness Research Sponsored by Pharmaceutical Companies
  New England Journal of Medicine, 1991
• Economic Assessment of Health Care: Theory and Practice
  Australian Economic Review, 1991
• Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues
  International Journal of Technology Assessment in Health Care, 1991
• OUTPUT MEASUREMENT FOR RESOURCE ALLOCATION DECISIONS IN HEALTH CARE
  Oxford Review of Economic Policy, 1989
• Economics of coronary artery bypass grafting.
  BMJ, 1985